GLP-1 Drugs Cut Glaucoma Risk in Nondiabetic Obesity

by Medscape • 2025/02/25 • 0 Comments

GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight loss medications in patients without diabetes diagnosed with obesity.
Medscape Medical News

← Celltrion espande il portfolio di biosimilari nell'Unione europea in seguito all'approvazione di due biosimilari da parte della Commissione europea

Study Finds No Vision Issues in Children With Vitiligo →

Post navigation